82 related articles for article (PubMed ID: 3494396)
1. Clinical and laboratory changes induced by alpha interferon in chronic lymphocytic leukemia--a pilot study.
Talpaz M; Rosenblum M; Kurzrock R; Reuben J; Kantarjian H; Gutterman J
Am J Hematol; 1987 Apr; 24(4):341-50. PubMed ID: 3494396
[TBL] [Abstract][Full Text] [Related]
2. Alpha-interferon receptors in malignant B-cells from patients with chronic lymphocytic leukemia: relation to induction of 2'-5'-oligoadenylate synthetase and blast transformation.
Ostlund L; Grandér D; Juliusson G; Robèrt KH; Lundgren E; Einhorn S
Cancer Res; 1989 Jun; 49(12):3425-30. PubMed ID: 2524252
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha inducible 2'-5' oligoadenylate synthetase transcripts in lymphoid and myeloid leukemias.
Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
Leukemia; 1993 May; 7(5):712-6. PubMed ID: 8483323
[TBL] [Abstract][Full Text] [Related]
4. Induction of 2',5'-oligoadenylate synthetase and blast transformation in primary chronic lymphocytic leukemia cells following exposure to interferon in vitro.
Ostlund L; Einhorn S; Robèrt KH
Cancer Res; 1986 Apr; 46(4 Pt 2):2160-3. PubMed ID: 2418964
[TBL] [Abstract][Full Text] [Related]
5. Alpha interferon therapy for haematological malignancies: correlation between in vivo induction of the 2',5'oligoadenylate system and clinical response.
de Mel WC; Hoffbrand AV; Giles FJ; Goldstone AH; Mehta AB; Ganeshaguru K
Br J Haematol; 1990 Apr; 74(4):452-6. PubMed ID: 2346724
[TBL] [Abstract][Full Text] [Related]
6. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase.
Rosenblum MG; Maxwell BL; Talpaz M; Kelleher PJ; McCredie KB; Gutterman JU
Cancer Res; 1986 Sep; 46(9):4848-52. PubMed ID: 2942242
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the biological and therapeutic effects of interferon-alpha in low-grade nodular non-Hodgkin's lymphoma: lack of in vivo down-regulation and reduced affinity of IFN-alpha receptors in unresponsive patients.
Billard C; Ferbus D; Diez RA; Kolb JP; Mathiot C; Belanger C; Auzanneau G; Varet B; Falcoff E; Dumont J
Leuk Res; 1991; 15(2-3):121-8. PubMed ID: 1826751
[TBL] [Abstract][Full Text] [Related]
8. Recombinant alpha 2-interferon in the treatment of B chronic lymphocytic leukemia in early stages.
Rozman C; Montserrat E; Viñolas N; Urbano-Ispizua A; Ribera JM; Gallart T; Compernolle C
Blood; 1988 May; 71(5):1295-8. PubMed ID: 3258768
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
[TBL] [Abstract][Full Text] [Related]
10. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.
Royston I; Majda JA; Baird SM; Meserve BL; Griffiths JC
J Immunol; 1980 Aug; 125(2):725-31. PubMed ID: 6993560
[TBL] [Abstract][Full Text] [Related]
11. Induction of interferon regulatory factors 2'-5' oligoadenylate synthetase, P68 kinase and RNase L in chronic myelogenous leukaemia cells and its relationship to clinical responsiveness.
Fischer T; Aman J; van der Kuip H; Rudolf G; Peschel C; Aulitzky WE; Huber C
Br J Haematol; 1996 Mar; 92(3):595-603. PubMed ID: 8616023
[TBL] [Abstract][Full Text] [Related]
12. Interferon system in primary acute lymphocytic leukemia cells with or without deletions of the alpha-/beta-interferon genes.
Grandér D; Heyman M; Bröndum-Nielsen K; Liu Y; Lundgren E; Söderhäll S; Einhorn S
Blood; 1992 Apr; 79(8):2076-83. PubMed ID: 1562733
[TBL] [Abstract][Full Text] [Related]
13. Recombinant leukocyte A interferon in B-cell chronic lymphocytic leukemia: in vivo effects on autologous antitumor immunity.
Schulof RS; Lloyd MJ; Stallings JJ; Mai D; Phillips TM; Jones GJ; Schechter GP
J Biol Response Mod; 1985 Jun; 4(3):310-23. PubMed ID: 3874930
[TBL] [Abstract][Full Text] [Related]
14. Production of interferon by peripheral blood mononuclear cells from normal individuals and patients with chronic lymphocytic leukemia.
Fernandez RC; Lee SH; Fernandez LA; Pope BL; Rozee KR
J Interferon Res; 1986 Oct; 6(5):573-80. PubMed ID: 3492575
[TBL] [Abstract][Full Text] [Related]
15. Recombinant alfa-2b-interferon therapy in untreated, stages A and B chronic lymphocytic leukemia. A preliminary report.
Pangalis GA; Griva E
Cancer; 1988 Mar; 61(5):869-72. PubMed ID: 3338053
[TBL] [Abstract][Full Text] [Related]
16. Positive effects of interferon-alpha on B cell-type chronic lymphocytic leukemia proliferative response.
Karray S; Delfraissy JF; Merle-Beral H; Wallon C; Debre P; Galanaud P
J Immunol; 1988 Feb; 140(3):774-8. PubMed ID: 3257503
[TBL] [Abstract][Full Text] [Related]
17. T-cell chronic lymphocytic leukemia with a helper/inducer membrane phenotype: a distinct clinicopathologic subtype with a poor prognosis.
Witzig TE; Phyliky RL; Li CY; Homburger HA; Dewald GW; Handwerger BS
Am J Hematol; 1986 Feb; 21(2):139-55. PubMed ID: 2934974
[TBL] [Abstract][Full Text] [Related]
18. The variable pattern of circulating lymphocyte subpopulations in chronic lymphocytic leukemia.
Davis S
N Engl J Med; 1976 May; 294(21):1150-3. PubMed ID: 1083483
[TBL] [Abstract][Full Text] [Related]
19. [Activation of the interferon system enzymes by recombinant alpha2-interferon in patients with chronic hepatitis B].
Sokolova TM; Bugaeva NP; Suetina IA; Ershov FI; Ketiladze ES
Antibiot Khimioter; 1989 Jun; 34(6):472-5. PubMed ID: 2552947
[TBL] [Abstract][Full Text] [Related]
20. 2-5A synthetase activity does not increase in interferon-resistant Friend leukemia cell variants treated with alpha/beta interferon despite the presence of high-affinity interferon receptor sites.
Affabris E; Romeo G; Belardelli F; Jemma C; Mechti N; Gresser I; Rossi GB
Virology; 1983 Mar; 125(2):508-12. PubMed ID: 6301152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
